
|Articles|March 1, 2002
PC-SPES not as beneficial for androgen-dependent PCa
New York-Some prostate cancer patients may be running to the healthfood store for supplements like PC-SPES, but the supplement cannot competewith other tried and true hormonal therapies, at least in men with androgen-dependentdisease, according to William Oh, MD.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Elizabeth Nally, MBBS, on decision regret and toxicity perception with adjuvant pembrolizumab
2
Neil Baum, MD, and Abraham Morgentaler, MD, discuss the history of testosterone and prostate cancer
3
The UroOnc Minute: Navigating BCG Maintenance Therapy in NMIBC, With Mark D. Tyson, II, MD, MPH
4
Optimizing care for men with overactive bladder, with Keith Xavier, MD
5






